EP4017494
VMAT2 hindrinn valbenasín til notkunar í aðferð til meðhöndlunar á tauga- eða geðröskun í sjúklingum með alvarlega nýrnaskerðingu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.8.2020EP published:
20.8.2025EP application number:
20764910.4
EP translation filed:
22.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
20.8.2040Expiry date:
20.8.2026Next due date:
31.8.2026
Title in English:
THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENTLanguage of the patent:
English
Timeline
Today
21.8.2020EP application
20.8.2025EP Publication
22.9.2025Translation submitted
15.10.2025Registration published
20.8.2026Expires
Owner
Name:
Neurocrine Biosciences, Inc.Address:
6027 Edgewood Bend Court, San Diego, CA 92130, US
Inventor
Name:
LOEWEN, Gordon RaphaelAddress:
Solana Beach, California 92075, US
Name:
LUO, Sha RosaAddress:
San Diego, California 92130, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962890697 PDate:
23.8.2019Country:
US
Number:
202063028754 PDate:
22.5.2020Country:
US
Classification
Categories:
A61K 31/4738, A61P 13/12, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/24, A61P 25/28, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 22.9.2025
Expires: 20.8.2026
Payer: Árnason Faktor ehf.